Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

551 studies match

clinicaltrialsPublishedShowing 101–150 of 551 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04148937	A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer	completed	Phase 1	52	Eli Lilly and CompanyINDUSTRY	3	Apr 5, 2024	clinicaltrials
NCT03703466	A Study of Abemaciclib (LY2835219) With and Without Food in Participants With Metastatic Breast Cancer	completed	Phase 2	72	Eli Lilly and CompanyINDUSTRY	5	Apr 2, 2024	clinicaltrials